The Evaluation of SATB2 as a Diagnostic Immunohistochemical Marker of Colorectal Adenocarcinoma in Comparison with Non-Colorectal Adenocarcinomas. Journal of Pharmaceutical Negative Results. Published online February 1, 2023:2280-2289. doi:10.47750/pnr.2023.14.02.278